Enalapril effects on renal function and ACE gene polymorphism in hypertensive nephropathy

Enalapril effects on renal function and ACE gene polymorphism in hypertensive nephropathy

Aim. To investigate the effects of enalapril on 24-hour proteinuria, renal function, intra-renal hemodynamics and survival, in regard to ACE gene polymorphism I/D, among patients with essential arterial hypertension (EAH). Material and methods. In total, 83 EAH patients were examined (mean age 41,48...

Full description

Bibliographic Details
Main Authors:	K. Y. Zholdoshov, R. R. Kaliev, A. A. Aldashev, A. B. Budaychieva, Ch. R. Sultakeeva, V. M. Ayylchieva
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2010-10-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	эссенциальная артериальная гипертония эналаприл скорость клубочковой фильтрации суточная протеинурия выживаемость полиморфизм гена ангиотензин-превращающего фермента
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/2122

Similar Items

Cardiovascular disease and ACE inhibitors: focusing on enalapril
by: G. A. Baryshnikova
Published: (2007-12-01)

ACE inhibitors in arterial hypertension management: zofenopril – class-specific effects and extra benefits
by: V. S. Zadionchenko, et al.
Published: (2007-04-01)

ACE inhibitors: new perspectives in cardiovascular disease treatment
by: V. I. Makolkin
Published: (2005-10-01)

Anti-remodeling efficacy of eprosartan in patients with essential hypertension, and gene polymorphism of angiotensin II type 1 receptors
by: B. Sh. Karimova, et al.
Published: (2005-02-01)

Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
by: T. V. Aparina, et al.
Published: (2005-06-01)

ACE inhibitor cilazapril: its place in cardiovascular diseases treatment
by: G. A. Baryshnikova
Published: (2005-08-01)

Moexipril in arterial hypertension treatment among postmenopausal women with osteoporosis
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Fixed-dose combination of perindopril and indapamide: perspectives in hypertensive patients with inadequately controlled blood pressure
by: I. E. Chazova, et al.
Published: (2007-02-01)

Predicting the overall survival of patients with chronic lymphocytic leukemia in the dynamics of the disease
by: M. V. Markovtseva, et al.
Published: (2023-10-01)

Dynamics of the main parameters of structure-functional condition of the left ventricle myocardium in usage of combination antihypertension therapy for postmenopausal women with different obesity patterns
by: V. V. Skibitsky, et al.
Published: (2016-04-01)

Comparison of various renal function assessment methods in patients with arterial hypertension
by: S. V. Villevalde, et al.
Published: (2008-08-01)

LIPID TRANSPORT GENETIC POLYMORPHISM AND ANGIOTENSIN-CONVERTING ENZYME I/D GENETIC POLYMORPHISM IN UZBEK PATIENTS WITH UNSTABLE ANGINA AND CORONARY HEART DISEASE IN FAMILY HISTORY
by: R. D. Kurbanov, et al.
Published: (2013-04-01)

Gender characteristics of the clinical manifestations of cardiovascular system involvement in X-linked Alport syndrome
by: O. S. Groznova, et al.
Published: (2016-07-01)

Effects of a fixed-dose combination of enalapnl and hydrochlorothiazide on carotid intima-media thickness in patients with arterial hypertension
by: O. D. Ostroumova, et al.
Published: (2009-08-01)

POTENTIAL OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN THE TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION AND CORONARY HEART DISEASE
by: A. G. Evdokimova, et al.
Published: (2013-02-01)

Vliyanie polimorfizma gena angiotenzin-I-prevrashchayushchego fermenta (APF) na antiproteinuricheskiy effekt ingibitorov APF u molodykh bol'nykh insulinzavisimym sakharnym diabetom
by: G I Sivous, et al.
Published: (1998-03-01)

Endothelial dysfunction in arterial hypertension: focus on the combination of trandolapril and verapamil
by: V. I. Makolkin
Published: (2010-08-01)

Arterial hypertension progression and changing activity of reninangiotensin-aldosterone and sympatho-adrenal systems
by: Sh. V. Akhadov, et al.
Published: (2010-04-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Pleiotropic ACE inhibitor effects: any benefits for sulfhydryl agents?
by: D. V. Preobrazhensky, et al.
Published: (2008-02-01)

New potential of ACE inhibitors in clinical practice
by: D. V. Nebieridze, et al.
Published: (2010-10-01)

Circadian blood pressure rhythm and renal function in males with essential arterial hypertension
by: I. G. Fomina, et al.
Published: (2006-08-01)

Comparative effectiveness of ACE inhibitors spirapril, fosinopril, and enalapril in complex therapy of patients with coronary heart disease, chronic obstructive pulmonary disease, and arterial hypertension
by: M. A. Popova, et al.
Published: (2006-06-01)

Effects of the fixed-dose combination therapy with indapamide and valsartan on renal function in patients with Type 2 diabetes mellitus and arterial hypertension
by: T. V. Malykh, et al.
Published: (2011-12-01)

Renal function and morning surge rate of systolic blood pressure in young hypertensive men aged under 35 years
by: I. G. Fomina, et al.
Published: (2008-06-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND CALCIUM ANTAGONIST COMBINATION IN PHARMACOTHERAPY OF ARTERIAL HYPERTENSION
by: L. L. Kirichenko, et al.
Published: (2014-02-01)

Left ventricular hypertrophy: renin4angiotensin system role
by: F. T. Ageev, et al.
Published: (2008-04-01)

EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES
by: O. A. Koshel'skaya, et al.
Published: (2015-12-01)

ACE inhibitors in arterial hypertension treatment among various clinical groups
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

COMBINATION THERAPY IN THE MANAGEMENT OF ARTERIAL HYPERTENSION: EFFECTIVENESS OF THE LERCANIDIPINE AND ENALAPRIL COMBINATION
by: L. O. Minushkina
Published: (2013-10-01)

Study of the features of microvasculature in patients with arterial hypertension and end-organ damage
by: L. A. Khaisheva, et al.
Published: (2014-08-01)

VESSEL WALL STIFFNESS IN ARTERIAL HYPERTENSION AND OPPORTUNITIES FOR ITS MODULATION
by: L. L. Kirichenko, et al.
Published: (2016-12-01)

Smoking effects on renal and central hemodynamics in men and women with essential arterial hypertension
by: V. I. Podzolkov, et al.
Published: (2009-12-01)

ВЛИЯНИЕ КОМБИНИРОВАННОЙ ТЕРАПИИ НА ЦЕНТРАЛЬНОЕ АРТЕРИАЛЬНОЕ ДАВЛЕНИЕ И АРТЕРИАЛЬНУЮ РИГИДНОСТЬ
Published: (2016-12-01)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
by: N. A. Berezneva, et al.
Published: (2013-05-01)

ACE inhibitors in patients with acute myocardial infarction
by: S. N. Tereshchenko, et al.
Published: (2005-08-01)

ACE inhibitor zofenopril in treatment of myocardial infarction patients: review of SMILE Project trials
by: Yu. M. Lopatin
Published: (2006-04-01)

Pharmacology of modern ACE inhibitors: moexipril example
by: D. P. Khloponin, et al.
Published: (2007-10-01)

Heart diastolic dysfunction in patients with familial arterial hypertension
by: B. A. Namakanov, et al.
Published: (2005-06-01)